Edan Instruments

Edan Instruments Short-term Debt

The Short-Term Debt of Edan Instruments (300206.SZ) as of Oct 27, 2026 is 6.64 M CNY. In the previous year, Short-Term Debt was 5.21 M CNY — a change of 27.42% (higher).

Short-term Debt

6.64 MCNY

YoY

27.42%

Last updated:

Short-Term Debt of Edan Instruments is 2023 6.64 M CNY. Short-Term Debt of Edan Instruments was 2022 5.21 M CNY. It decreases by 27.42% higher compared to the previous year.

The Edan Instruments Short-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Short-term Debt
Date
Short-term Debt
Jan 1, 2015
15.00 M CNY
Jan 1, 2016
45.00 M CNY
Jan 1, 2019
-30.14 M CNY
Jan 1, 2020
99.80 M CNY
Jan 1, 2021
60.00 M CNY
Jan 1, 2022
5.21 M CNY
Jan 1, 2023
6.64 M CNY
The Edan Instruments Short-term Debt history
YEARShort-term DebtYoY
6.64 MCNY+27.42%
5.21 MCNY-91.31%
60.00 MCNY-39.88%
99.80 MCNY-431.18%
-30.14 MCNY-166.97%
45.00 MCNY+200.00%
15.00 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

Short-Term Debt of Edan Instruments is 6.64 M CNY in 2023.

Short-Term Debt of Edan Instruments changed from 5.21 M CNY to 6.64 M CNY, representing a 27.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Short-Term Debt Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

Short-term debt represents borrowings due within one year. High short-term debt relative to cash can signal liquidity risk.

Short-Term Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Short-Term Debt's Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Edan Instruments

All Key Metrics — Edan Instruments